• eTheRNA extends leadership team with the appointment of Dr. Volker Germaschewski as Senior Vice President for R&D

    Wednesday March 10th 2021

  • AgomAb Therapeutics kondigt $74 miljoen series-B financiering aan

    Wednesday March 10th 2021

  • VIB announces complete development of COVID-19 antibody, and its effectiveness against new variants

    Wednesday March 10th 2021

  • Mithra and Searchlight Pharma announce Estelle® approval in Canada

    Monday March 8th 2021

  • Cardiology prepared for fourth dimension

    Friday March 5th 2021

  • Galapagos reports primary endpoint for the ongoing filgotinib MANTA and MANTA-RAy safety studies

    Thursday March 4th 2021

  • argenx announces FDA acceptance of BLA filing for Efgartigimod for the treatment of generalized myasthenia gravis

    Wednesday March 3rd 2021

  • Mithra and Farmitalia announce commercial launch of Myring™ in Italy

    Wednesday March 3rd 2021

  • Your news here?

  • Rejuvenate Biomed secures EUR 3.2 million series A round to advance development of healthy aging products

    Tuesday March 2nd 2021

  • European Centre for Disease Prevention and Control (ECDC) intensifies the identification and tracking of mutations of the SARSCoV-2 genome across Europe with support of Eurofins Genomics

    Friday February 26th 2021

  • AbolerIS Pharma strengthens management team to support next phases of growth

    Friday February 26th 2021


Strategic Partners